These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30683605)

  • 21. Effect of anemia and hyperhomocysteinemia on mortality of patients on hemodialysis.
    Anees M; Mumtaz A; Ibrahim M; Shaheen SM; Asghar A
    Iran J Kidney Dis; 2010 Jan; 4(1):60-5. PubMed ID: 20081306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton Pump Inhibitors and Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: Results from the Japan Dialysis Outcomes and Practice Patterns Study.
    Nakashima A; Miyawaki Y; Komaba H; Kurita N; Onishi Y; Yokoo T; Fukagawa M
    Am J Nephrol; 2024; 55(2):165-174. PubMed ID: 37935135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients.
    Honda H; Michihata T; Shishido K; Takahashi K; Takahashi G; Hosaka N; Ikeda M; Sanada D; Shibata T
    PLoS One; 2017; 12(5):e0176984. PubMed ID: 28475601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
    Coyne DW; Kapoian T; Suki W; Singh AK; Moran JE; Dahl NV; Rizkala AR;
    J Am Soc Nephrol; 2007 Mar; 18(3):975-84. PubMed ID: 17267740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia.
    Majoni SW; Ellis JA; Hall H; Abeyaratne A; Lawton PD
    Hemodial Int; 2014 Oct; 18(4):740-50. PubMed ID: 24766376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Transferrin Saturation on All-Cause Mortality in Patients on Maintenance Hemodialysis.
    Sato M; Hanafusa N; Tsuchiya K; Kawaguchi H; Nitta K
    Blood Purif; 2019; 48(2):158-166. PubMed ID: 31311016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of renal anemia with iron in hemodialysis patients in General Hospital Bjelovar].
    Lovcić V; Vujić J; Basić-Jukić N; Janković RI; Kurtović I; Dzapo M; Lovcić P
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():45-8. PubMed ID: 23120815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Achievement of renal anemia KDIGO targets by two different clinical strategies - a European hemodialysis multicenter analysis.
    Drozdz M; Weigert A; Silva F; Frazão J; Alsuwaida A; Krishnan M; Kleophas W; Brzosko S; Johansson FK; Jacobson SH
    BMC Nephrol; 2019 Jan; 20(1):5. PubMed ID: 30616548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial Effects of Oral Iron in Japanese Patients on Hemodialysis.
    Sanai T; Ono T; Fukumitsu T
    Intern Med; 2017 Sep; 56(18):2395-2399. PubMed ID: 28824065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anemia and iron target realization in 1998: clinical management of anemia in 1,639 patients on hemodialysis.
    Salahudeen AK; Fleischmann E; Ahmed A; Bower JD
    ASAIO J; 2001; 47(5):511-5. PubMed ID: 11575828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemoglobin level and survival in hemodialysis patients with polycystic kidney disease and the role of administered erythropoietin.
    Shah A; Molnar MZ; Lukowsky LR; Zaritsky JJ; Kovesdy CP; Kalantar-Zadeh K
    Am J Hematol; 2012 Aug; 87(8):833-6. PubMed ID: 22641426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
    Vanková S; Safárová R; Horácková M; Herink J; Rychlík I; Bahbouh R; Půtová I
    Cas Lek Cesk; 2001 Apr; 140(7):209-13. PubMed ID: 11374225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the effectiveness of IV iron dosing for anemia management in common clinical practice: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Robinson BM; Larkina M; Bieber B; Kleophas W; Li Y; Locatelli F; McCullough KP; Nolen JG; Port FK; Pisoni RL
    BMC Nephrol; 2017 Nov; 18(1):330. PubMed ID: 29121874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between vitamin D receptor (FokI) genetic variant rs2228570 and iron profile in hemodialysis patients.
    Al-Shaer OS; Behiry EG; Ahmed AA; Moustafa HH
    Mol Biol Rep; 2020 Jan; 47(1):545-553. PubMed ID: 31679114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors related to the absence of anemia in hemodialysis patients.
    Verdalles U; Abad S; Vega A; Ruiz Caro C; Ampuero J; Jofre R; Lopez-Gomez JM
    Blood Purif; 2011; 32(1):69-74. PubMed ID: 21346339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thresholds of iron markers for iron deficiency erythropoiesis-finding of the Japanese nationwide dialysis registry.
    Hamano T; Fujii N; Hayashi T; Yamamoto H; Iseki K; Tsubakihara Y
    Kidney Int Suppl (2011); 2015 Jun; 5(1):23-32. PubMed ID: 26097782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
    Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
    Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inter-Method Variability of Ferritin and Transferrin Saturation Measurement Methods in Patients on Hemodialysis.
    Kamei D; Tsuchiya K; Miura H; Nitta K; Akiba T
    Ther Apher Dial; 2017 Feb; 21(1):43-51. PubMed ID: 27957820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.
    Kaneko Y; Miyazaki S; Hirasawa Y; Gejyo F; Suzuki M
    Kidney Int; 2003 Mar; 63(3):1086-93. PubMed ID: 12631092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.